David J. Rawlings

Active 1980–2025

124
Papers
19,943
Citations
81
h-index
118
i10-index

Citations

Citations per year for David J. Rawlings1983: 2 citations1984: 4 citations1987: 1 citations1988: 1 citations1993: 20 citations1994: 70 citations1995: 71 citations1996: 102 citations1997: 98 citations1998: 128 citations1999: 193 citations2000: 181 citations2001: 131 citations2002: 115 citations2003: 124 citations2004: 165 citations2005: 147 citations2006: 118 citations2007: 155 citations2008: 146 citations2009: 185 citations2010: 164 citations2011: 121 citations2012: 165 citations2013: 201 citations2014: 169 citations2015: 168 citations2016: 155 citations2017: 168 citations2018: 173 citations2019: 569 citations2020: 624 citations2021: 885 citations2022: 565 citations2023: 351 citations2024: 542 citations2025: 258 citations2026: 4 citations1985–1986: no citations, so these years are not shown1989–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,890 citing papers, 32.9% of this breakdownChina: 799 citing papers, 9.1% of this breakdownUnited Kingdom: 626 citing papers, 7.1% of this breakdownGermany: 570 citing papers, 6.5% of this breakdownFrance: 372 citing papers, 4.2% of this breakdownCanada: 315 citing papers, 3.6% of this breakdownJapan: 315 citing papers, 3.6% of this breakdownItaly: 270 citing papers, 3.1% of this breakdownAustralia: 224 citing papers, 2.6% of this breakdownSwitzerland: 223 citing papers, 2.5% of this breakdownNetherlands: 201 citing papers, 2.3% of this breakdownSpain: 159 citing papers, 1.8% of this breakdown
0%32.9%Other 20.7%

Fields

  • Medicine39.1%
  • Immunology and Microbiology29.1%
  • Biochemistry, Genetics and Molecular Biology27.5%
  • Chemistry1.7%
  • Neuroscience1.2%
  • Agricultural and Biological Sciences0.4%
  • Other1%

Topics

  • T-cell and B-cell Immunology8.5%
  • Immune Cell Function and Interaction7.2%
  • Immunodeficiency and Autoimmune Disorders3.4%
  • Chronic Lymphocytic Leukemia Research3.2%
  • Immunotherapy and Immune Responses2.8%
  • CRISPR and Genetic Engineering2.6%
  • Other72.3%

Coauthors

All papers

Open in search
  1. CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

    Authors: , , , , , , - Immunity 2010 cited by 1,533

  2. Altered B cell signalling in autoimmunity

    Authors: , , , - Nature reviews. Immunology 2017 cited by 301

  3. Pancreatic islet-specific engineered T regs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2022 cited by 77

  4. B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity

    Authors: , , , , , , , - The Journal of Experimental Medicine 2017 cited by 265

  5. Gene editing to induce FOXP3 expression in human CD4 + T cells leads to a stable regulatory phenotype and function

    Authors: , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 117

  6. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6

    Authors: , , , , , , , , - The Journal of Experimental Medicine 2016 cited by 216

  7. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell 2020 cited by 713

  8. NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2016 cited by 230

  9. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia

    Authors: , , , , , , , , , , , , , - Cell 1993 cited by 1,346

  10. Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells

    Authors: , , , , , , , , , - Molecular Therapy 2017 cited by 148

  11. Integration of B cell responses through Toll-like receptors and antigen receptors

    Authors: , , , - Nature reviews. Immunology 2012 cited by 329

  12. Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template

    Authors: , , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 229

  13. Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells

    Authors: , , , , , , , , - Molecular Therapy 2017 cited by 166

  14. PTPN22 regulates NLRP3-mediated IL1B secretion in an autophagy-dependent manner

    Authors: , , , , , , , - Autophagy 2017 cited by 129

  15. pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences

    Authors: , , , , , , , , , , - Molecular Therapy — Nucleic Acids 2016 cited by 88

  16. GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JCI Insight 2024 cited by 50

  17. Tracking genome engineering outcome at individual DNA breakpoints

    Authors: , , , , , , - Nature Methods 2011 cited by 334

  18. A RANKL–PKCβ–TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts

    Authors: , , , , , , , - Genes & Development 2013 cited by 177

  19. Multiplexed Functional Assessment of Genetic Variants in CARD11

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2020 cited by 81

  20. Interleukin-4 downregulates transcription factor BCL6 to promote memory B cell selection in germinal centers

    Authors: , , , , , , , - Immunity 2024 cited by 49

  21. Dual-locus, dual-HDR editing permits efficient generation of antigen-specific regulatory T cells with robust suppressive activity

    Authors: , , , , , , - Molecular Therapy 2023 cited by 22

  22. Opposing Impact of B Cell–Intrinsic TLR7 and TLR9 Signals on Autoantibody Repertoire and Systemic Inflammation

    Authors: , , , , , , , , , - The Journal of Immunology 2014 cited by 165

  23. Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo

    Authors: , , , , , , , , , , , - Nature Communications 2022 cited by 56

  24. Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis

    Authors: , , , , , , - The Journal of Immunology 2007 cited by 551